Follow
Phillippa Taberlay
Title
Cited by
Cited by
Year
Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations
PC Taberlay, J Achinger-Kawecka, ATL Lun, FA Buske, K Sabir, ...
Genome research 26 (6), 719-731, 2016
3352016
DNA methylation screening identifies driver epigenetic events of cancer cell survival
DD De Carvalho, S Sharma, JS You, SF Su, PC Taberlay, TK Kelly, ...
Cancer cell 21 (5), 655-667, 2012
3252012
Mining cancer methylomes: prospects and challenges
C Stirzaker, PC Taberlay, AL Statham, SJ Clark
Trends in Genetics 30 (2), 75-84, 2014
2272014
The DNA methylation landscape in cancer
K Skvortsova, C Stirzaker, P Taberlay
Essays in biochemistry 63 (6), 797-811, 2019
2092019
Reconfiguration of nucleosome-depleted regions at distal regulatory elements accompanies DNA methylation of enhancers and insulators in cancer
PC Taberlay, AL Statham, TK Kelly, SJ Clark, PA Jones
Genome research 24 (9), 1421-1432, 2014
2082014
Polycomb-repressed genes have permissive enhancers that initiate reprogramming
PC Taberlay, TK Kelly, CC Liu, JS You, DD De Carvalho, TB Miranda, ...
Cell 147 (6), 1283-1294, 2011
1992011
OCT4 establishes and maintains nucleosome-depleted regions that provide additional layers of epigenetic regulation of its target genes
JS You, TK Kelly, DD De Carvalho, PC Taberlay, G Liang, PA Jones
Proceedings of the National Academy of Sciences 108 (35), 14497-14502, 2011
1612011
DNA methylation and cancer
PC Taberlay, PA Jones
Epigenetics and Disease: Pharmaceutical Opportunities, 1-23, 2011
1532011
Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains
A Khoury, J Achinger-Kawecka, SA Bert, GC Smith, HJ French, PL Luu, ...
Nature communications 11 (1), 54, 2020
842020
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition
SJ Hogg, O Motorna, LA Cluse, TM Johanson, HD Coughlan, R Raviram, ...
Molecular cell 81 (10), 2183-2200. e13, 2021
682021
Chromatin remodeler mutations in human cancers: epigenetic implications
KA Skulte, L Phan, SJ Clark, PC Taberlay
Epigenomics 6 (4), 397-414, 2014
462014
Neurofilament-labeled pyramidal neurons and astrocytes are deficient in DNA methylation marks in Alzheimer's disease
AJ Phipps, JC Vickers, PC Taberlay, A Woodhouse
Neurobiology of Aging 45, 30-42, 2016
372016
Interplay between transcription factors and the epigenome: insight from the role of RUNX1 in leukemia
KH Brettingham-Moore, PC Taberlay, AF Holloway
Frontiers in immunology 6, 2015
352015
Alterations in three-dimensional organization of the cancer genome and epigenome
J Achinger-Kawecka, PC Taberlay, SJ Clark
Cold Spring Harbor Symposia on Quantitative Biology 81, 41-51, 2016
342016
Integrated epigenomic analysis stratifies chromatin remodellers into distinct functional groups
KA Giles, CM Gould, Q Du, K Skvortsova, JZ Song, MP Maddugoda, ...
Epigenetics & Chromatin 12, 1-19, 2019
312019
Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1
PC Oakford, SR James, A Qadi, AC West, SN Ray, AG Bert, PN Cockerill, ...
Leukemia research 34 (9), 1203-1213, 2010
292010
Targeting epigenetic modifiers in cancer
AF Holloway, PC Oakford
Current medicinal chemistry 14 (24), 2540-2547, 2007
242007
Determinants of a transcriptionally competent environment at the GM-CSF promoter
KH Brettingham-Moore, OR Sprod, X Chen, P Oakford, MF Shannon, ...
Nucleic acids research 36 (8), 2639-2653, 2008
212008
DNA methylation changes following DNA damage in prostate cancer cells
LP Sutton, SA Jeffreys, JL Phillips, PC Taberlay, AF Holloway, M Ambrose, ...
Epigenetics 14 (10), 989-1002, 2019
202019
Age, but not amyloidosis, induced changes in global levels of histone modifications in susceptible and disease-resistant neurons in Alzheimer’s disease model mice
M Dyer, AJ Phipps, S Mitew, PC Taberlay, A Woodhouse
Frontiers in aging neuroscience 11, 68, 2019
152019
The system can't perform the operation now. Try again later.
Articles 1–20